Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)
Q3 2016 Earnings Conference Call
November 15, 2016 08:00 AM ET
Executives
Kevin Mannix - SVP, IR
Erez Vigodman - CEO
Eyal Desheh - CFO
Siggi Olafsson - President and CEO, Global Generic Medicines
Rob Koremans - President and CEO, Global Specialty Medicines
Michael Hayden - Head of R&D, Chief Scientific Officer
Carlo De Notaristefani - President and CEO, Global Operations
David Stark - Chief Legal Officer
Analysts
Louise Chen - HSBC
Vamil Divan - Credit Suisse
Tim Chiang - BTIG
Ken Cacciatore - Cowen and Company
David Risinger - Morgan Stanley
David Amsellam - Piper Jaffray
Randall Stanicky - RBC Capital Markets
Umer Raffat - Evercore ISI
David Maris - Wells Fargo
Marc Goodman - UBS
Liav Abraham - Citi
Gregg Gilbert - Deutsche Bank Research
Ronny Gal - Sanford C. Bernstein & Co., LLC
Jami Rubin - Goldman Sachs & Co.
Chris Schott - JPMorgan
